Spotlight on 17‐AAG as an Hsp90 inhibitor for molecular targeted cancer treatment - Talaei - 2019 - Chemical Biology & Drug Design - Wiley Online Library
Cross-resistance of 17-AAG resistant GB cell lines with other HSP90... | Download Scientific Diagram
Frontiers | A Novel Mechanism of 17-AAG Therapeutic Efficacy on HSP90 Inhibition in MYCN-Amplified Neuroblastoma Cells | Oncology
New agents in cancer clinical trials | Oncogene
17-AAG - ABILITY, TOXICITY, SOLUBILITY
Tanespimycin - Wikipedia
Altered states: selectively drugging the Hsp90 cancer chaperone: Trends in Molecular Medicine
The small-molecule kinase inhibitor D11 counteracts 17-AAG-mediated up-regulation of HSP70 in brain cancer cells | PLOS ONE
17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration | Nature Medicine
Effect of 17-AAG on cell proliferation and Hsp90 client protein levels.... | Download Scientific Diagram
Pharmaceuticals | Free Full-Text | Heat Shock Protein 90 and Role of Its Chemical Inhibitors in Treatment of Hematologic Malignancies | HTML
Frontiers | Inhibition of Heat Shock Protein 90 by 17-AAG Reduces Inflammation via P2X7 Receptor/NLRP3 Inflammasome Pathway and Increases Neurogenesis After Subarachnoid Hemorrhage in Mice | Molecular Neuroscience
Tanespimycin - an overview | ScienceDirect Topics
Synthesis and biological evaluation of geldanamycin–ferulic acid conjugate as a potent Hsp90 inhibitor - RSC Advances (RSC Publishing) DOI:10.1039/C9RA08665J
Frontiers | A Novel Mechanism of 17-AAG Therapeutic Efficacy on HSP90 Inhibition in MYCN-Amplified Neuroblastoma Cells | Oncology
Molecular Stress-inducing Compounds Increase Osteoclast Formation in a Heat Shock Factor 1 Protein-dependent Manner* - Journal of Biological Chemistry
Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90 | PNAS
Retaspimycin - an overview | ScienceDirect Topics
17-AAG
In vitro study comparing the efficacy of the water-soluble HSP90 inhibitors, 17-AEPGA and 17-DMAG, with that of the non‑water-soluble HSP90 inhibitor, 17-AAG, in breast cancer cell lines
Frontiers | A Novel Mechanism of 17-AAG Therapeutic Efficacy on HSP90 Inhibition in MYCN-Amplified Neuroblastoma Cells | Oncology
Synthesis and biological evaluation of geldanamycin–ferulic acid conjugate as a potent Hsp90 inhibitor - RSC Advances (RSC Publishing) DOI:10.1039/C9RA08665J
Ganetespib: research and clinical development | OTT
Nanomedicines Targeting Heat Shock Protein 90 Gene Expression in the Therapy of Breast Cancer - Zaib - 2022 - ChemistrySelect - Wiley Online Library
Tumor Suppression Efficacy of Heat Shock Protein 90 Inhibitor 17AAG in a Liposarcoma Mouse Model | Anticancer Research
Structural development of HSP90 inhibitors. Geldanamycin (I) and... | Download Scientific Diagram
Targeting Heat Shock Protein 90 for the Treatment of Malignant Pheochromocytoma | PLOS ONE
